Alpha thalassemia
Dernière mise à jour 17 juin 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Alpha thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body.
Sélections vidéo pour Conditions génétiquesBibliothèque vidéo
Description
Alpha thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen to cells throughout the body.
In people with the characteristic features of alpha thalassemia, a reduction in the amount of hemoglobin prevents enough oxygen from reaching the body's tissues. Affected individuals also have a shortage of red blood cells (anaemia), which can cause pale skin, weakness, fatigue, and more serious complications.
Two types of alpha thalassemia can cause health problems. The more severe type is known as hemoglobin Bart hydrops fetalis syndrome, which is also called Hb Bart syndrome or alpha thalassemia major. The milder form is called HbH disease.
Hb Bart syndrome is characterised by hydrops fetalis, a condition in which excess fluid builds up in the body before birth. Additional signs and symptoms can include severe anaemia, an enlarged liver and spleen (hepatosplenomegaly), heart defects, and abnormalities of the urinary system or genitalia. Without treatment, most babies with this condition are stillborn or die soon after birth because of these serious health problems. Hb Bart syndrome can also cause serious complications for women during pregnancy, including dangerously high blood pressure with swelling (preeclampsia), premature delivery, and abnormal bleeding.
HbH disease causes mild to moderate anaemia, hepatosplenomegaly, and yellowing of the eyes and skin (jaundice). The features of HbH disease usually appear in early childhood, and affected individuals typically live into adulthood.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Related genes
Other names
Alpha-thalassemia
Α-thalassemia
Related patient information and medicines

Patient information leaflet
Thalassémie
Thalassaemia is an inherited condition affecting the blood. ... The main types of thalassaemia are called alpha thalassaemia and beta thalassaemia. The more severe beta types are beta thalassaemia major (BTM) and beta thalassaemia intermedia (BTI). The more severe alpha forms are Hb Barts (very severe) and HbH disease (moderate). There are also.

Patient information leaflet
Insuffisance hépatique
Diseases of the veins in the liver Some diseases (for example, Budd-Chiari syndrom... Metabolic diseases Some rare metabolic diseases may cause acute liver failure. These include haemochromatosis Haemochromatosis , alpha-1 antitrypsin deficiency Alpha-1 antitrypsin deficiency , Wilson's disease Wilson's disease , fructose intolerance,.

Patient information leaflet
Syndrome des jambes sans repos
Lack of iron (iron de. If this is the cause then the symptoms of RLS usually go if you take iron tablets. Also after a time on dopamine agonists, symptoms can suddenly become much worse. If this is the case, you will need to stop or change your medication. Ligands alpha-2-delta This is another group of recommended medicines (although they do not.

Patient information leaflet
Vasodilatateurs périphériques
Vasodilatateurs périphériques sont les médicaments that are used to treat conditions cela affect blood vessels in outer (peripheral) parts of the body such as the arms and legs. For example, they are used to treat peripheral arterial disease and Raynaud's phenomenon. Nifedipine Nifedipine is a type of medicine called a calcium-channel blocker. Moxisylyte is a.

Patient information leaflet
Spina bifida
Very mild forms (spinal bifida occulta), in which there are no symptoms, may never be detected. Before birth The most common screening methods used to look for spina bifida during la grossesse are the sang test for alpha-foetoprotéine and an ultrasound scan, which are routinely performed at 16-18 weeks of pregnancy. See the separate leaflet called.

Patient information leaflet
COVID-19
There is also some concern that existing vaccines and treatments might be less effective against the variants. However, in some cases, they also seem to be less likely to cause serious illness. Notable variants of SARS CoV-2 include: the alpha variant; beta variant; delta variant; and omicron variant. Who is at risk of catching COVID. Anyone can.
Lectures complémentaires et références
- Alpha thalassemia; MedlinePlus, National Library of Medicine.
- Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003 Feb 1;101(3):791-800. doi: 10.1182/blood-2002-07-1975. Epub 2002 Sep 12. No abstract available.
- Chui DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25-32. doi: 10.1196/annals.1345.004.
- Higgs DR, Weatherall DJ. The alpha thalassaemias. Cell Mol Life Sci. 2009 Apr;66(7):1154-62. doi: 10.1007/s00018-008-8529-9.
- Leung WC, Leung KY, Lau ET, Tang MH, Chan V. Alpha-thalassaemia. Semin Fetal Neonatal Med. 2008 Aug;13(4):215-22. doi: 10.1016/j.siny.2008.02.006. Epub 2008 Apr 10.
- Tamary H, Greenberg-Kushnir N, Dgany O. Alpha-Thalassemia. 2005 Nov 1 [updated 2026 Apr 23]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1435/
- Urbinati F, Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part II: thalassaemias. Expert Rev Mol Med. 2006 May 9;8(10):1-26. doi: 10.1017/S1462399406010805.
- Vichinsky EP. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009:35-41. doi: 10.1182/asheducation-2009.1.35.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-12. Epub 2001 Oct 24.
Historique de l'article
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
17 juin 2024 | Dernière version
1 déc. 2022 | Publié à l'origine
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

